Advertise
NEWSLETTER
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Longevity start now
Reason

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Thomas Weldon

Rejuvant – starting Longevity now

Longevity: Start now … Introduction

Johnny Adams, CEO / Executive Director, Aging Intervention Foundation; Executive Director, Gerontology Research Group

How can BioViva address the here and now?

Results of exogenous GDF11 supplementation in over 100 human volunteers – the view of Patient Zero

Navigating the labyrinth of dietary restriction methods

Forever Healthy – ensuring a healthy Longevity

Dr Oliver Zolman makes the case for longevity companies to adopt a check list when it comes to making anti-aging claims.

Prescribing Longevity

Philip Milgram

Prescribing Longevity Stateside

Biohack your way to Longevity

The Death of Death: the three bridges to physical immortality

What is making a transhumanist wager?

‘Longevity: Start now’ Ask Me Anything

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed